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June Supplement 201092S Abstractsgrowth (p  0.4). No difference was noted in the need for
secondary interventions between groups. However, group A
patients that did not experience growth were more likely to
develop a distal type I endoleak than groupBpatients whodid
not develop growth (p  0.03). There was no difference in
SAE between groups (p  0.51). However, patients that
developed iliac artery growth in either groupwere less likely to
have a SAE compared to patients who did not experience
growth (p  0.035). There was no difference in the mean
percent oversizing of the iliac limbs between groups A and B.
However, themean percent oversizing in groups A andB that
had iliac artery growth was significantly higher than in those
that demonstrated no growth (p 0.01).
Conclusions: Aneurysmal iliac arteries managed by
flared limbs or external iliac extensions at the time of EVAR
for AAA do not demonstrate future iliac growth, in-
creased rate of secondary interventions or serious adverse
events compared to patients with normal iliac arteries.
This suggests that aneurysmal iliac arteries can be safely
treated with appropriately-sized limbs landed in the
common or external iliac artery.
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Objectives: Male gender and family history are impor-
tant risk factor for abdominal aortic aneurysm (AAA). We
hypothesised that genes involved in sex hormones produc-
tion and action might be important in aortic dilatation. We
investigated the association of aortic diameter with single
nucleotide polymorphisms (SNPs) in genes determining
circulating sex hormones and their action.
Methods:Wegenotyped74 tagging SNPs across 4 genes
(steroid 5 reductase, subfamily A, polypeptide 1 (SRD5A1),
cytochrome P450, family 19, subfamily A, polypeptide 1
(CYP19A1), androgen receptor (AR) and estrogen receptor 2
(ESR2)) related to sex hormone production and action in
1711men, 640 ofwhomhad anAAA (mean diameter 36.1
6.7mm). Associations were assessed adjusting for other risk
factors for AAA, including age, smoking, coronary heart dis-
ease, hypertension, dyslipidemia and diabetes.
Results:One SNP inCYP19A1was strongly associated
with aortic diameter. Subjects who had the rare homozy-
gote genotype (TT) for CYP19A1 g.49412370CT (SNPID rs1961177), had increased aortic diameter (coefficient
4.872, standard error 1.394, p 0.0004, under a recessive
model adjusting for other risk factors). Four haplotypes in
CYP19A1 were demonstrated to be significantly associated
with aortic diameter, after adjusting for other risk factors
and multiple testing. In particular the relative common
haplotype CTT defined by the g.49386747CG (SNP ID
rs17523922), g.49394252CT (SNP ID rs3751591),
and g.49412370CT (SNP ID rs1961177) which was
present in 10% of men, p  0.0001.
Conclusions: Our findings support an association be-
tween one SNP in CYP19A1 and aortic diameter which
warrants validation in other cohorts.
Author Disclosures: E. Biros: Nothing to disclose; M.
Cooper: Nothing to disclose; J. Golledge: Nothing to dis-
close;G. Jones: Nothing to disclose;P. Norman: Nothing to
disclose;L. Palmer: Nothing to disclose;A. van Rij: Nothing
to disclose; N. Warrington: Nothing to disclose.
RR12.
Disease Progression Following Initial Surgical Inter-
vention for Takayasu’s Arteritis
Sung W. Ham, Ram K. Subramanyan, Vincent L. Rowe,
Fred A. Weaver. Surgery, University of Southern Califor-
nia, Los Angeles, CA
Objectives: To determine the incidence of disease pro-
gression and the need for subsequent revascularization
procedures in patients with Takayasu’s Arteritis (TA).
Methods: From 1980 - 2009, 40 patients (36 women,
mean age 35) with TA underwent an initial revasculariza-
tion procedure for end organ ischemia. The incidence of
subsequent revascularization in another vascular bed or
revision of the initial procedure was determined.
Results: Indications for the initial procedure were hyper-
tension (20), renal dysfunction (9), extremity ischemia (6),
and stroke/TIA (5). Initial revascularization included 36 by-
pass procedures and 4 endovascular interventions. Over a
mean follow-up of 6.4 years, 16 (40%) patients had either
progression of TA in another vascular bed or stenosis/occlu-
sion of the initial revascularization procedure. Five patients
with progression required 1 procedure whereas 11 required 2
or more surgical interventions. Procedures required included:
renal (11), carotid (5), extremity (5), iliac (2), subclavian (2),
abdominal aorta (2), thoracic aorta (1), and mesenteric (1).
Postoperative/30-day morbidity was 14% and there was one
operative death. One and 5-year actuarial survival were 94%
and 94%, respectively.
Conclusions: Progression of TA is a common occur-
rence in patients who require revascularization for end
organ ischemia. This finding emphasizes the need for
global lifelong vascular surveillance of all patients who
undergo surgical intervention for Takayasu’s steritis.
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